Related content

A phase I study of neoadjuvant chemotherapy with gemcitabine plus oral S-1 for resectable pancreatic cancer

By                                          

Molecular and Clinical Oncology, Vol. 1, Iss. 4, 2013-01 ,pp. : 768-772

Spandidos Publications

Access to resources Recommend Favorite

A phase II clinical trial of polyethylene glycol-conjugated L-asparaginase in patients with advanced ovarian cancer: Early closure for safety

By Hays  

Molecular and Clinical Oncology, Vol. 1, Iss. 3, 2013-01 ,pp. : 565-569

Spandidos Publications

Access to resources Recommend Favorite

Phase II study on the combination of irinotecan plus cisplatin as a secondline therapy in patients with advanced or recurrent gastric cancer

By                    

Molecular and Clinical Oncology, Vol. 1, Iss. 4, 2013-01 ,pp. : 749-752

Spandidos Publications

Access to resources Recommend Favorite

Myeloid Progenitor Cell Proliferation and Mobilization Effects of BB10010, a Genetically Engineered Variant of Human Macrophage Inflammatory Protein-1, in a Phase I Clinical Trial in Patients with Relapsed/Refractory Breast Cancer

By Broxmeyer H.E.   Orazi A.   Hague N.L.   Sledge G.W.   Rasmussen H.   Beutler M.E.S.  

Blood Cells, Molecules, and Diseases, Vol. 24, Iss. 1, 1998-03 ,pp. : 14-30

Academic Press

Access to resources Recommend Favorite

Phase I Safety, Tolerability, and Pharmacokinetic Study of Recombinant Human Mannan-Binding Lectin

By Petersen Kenneth   Matthiesen Finn   Agger Teit   Kongerslev Leif   Thiel Steffen   Cornelissen Karen   Axelsen Mads  

Journal of Clinical Immunology, Vol. 26, Iss. 5, 2006-09 ,pp. : 465-475

Springer Publishing Company

Access to resources Recommend Favorite